Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Cholest-4-en-3-one, oxime

EU orphan designation number: EU/3/05/264   
Active ingredient: Cholest-4-en-3-one, oxime
Indication: Treatment of 5q spinal muscular atrophy
Sponsor: Roche Registration Limited
6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/03/2005 Orphan designation EMEA/OD/081/04 (2005)816 of 10/03/2005
16/12/2015 Transfer of orphan designation EMA/OD/081/04/T/01 (2015)8668 of 30/11/2015